Simple injection could limit damage from heart attacks and stroke

Simple-injection-could-limit-damage-from-heart-attacks-and-stroke.jpg

NEW research offers promise of a simple injection that could be developed to limit the devastating consequences of heart attacks and strokes. Described by the lead researcher as ‘a fascinating new achievement’, work has already begun to translate the research into novel clinical therapies.
The University of Leicester led an international team whose research has been published in the Proceedings of the National Academy of Sciences (PNAS).
Professor Wilhelm Schwaeble of the Department of Infection, Immunity and Inflammation at the University of Leicester, initiated and co-ordinated research collaborations with King’s College London, the Medical University of Fukushima, Japan and the State University of New York, to achieve the present breakthrough findings, which were published in PNAS.
Professor Schwaeble and collaborators identified an enzyme, Mannan Binding Lectin-Associated Serine Protease-2 (MASP-2), that is found in blood and is a key component of the lectin pathway of complement activation, a component of the innate immune system.
The lectin pathway is responsible for the potentially devastating inflammatory tissue response that can occur when any bodily tissue or organ is reconnected to blood supply following ischaemia — a temporary loss of that blood supply and the oxygen that it carries.
This excessive inflammatory response is, in part, responsible for the morbidity and mortality associated with myocardial infarction (heart attack) and cerebrovascular accidents (CVAs or strokes). Moreover, the work succeeded in finding a way to neutralise this enzyme by raising a therapeutic antibody against it. A single antibody injection in animals has been shown to be sufficient to disrupt the molecular process that leads to tissue and organ destruction following ischaemic events, resulting in significantly less damage and markedly improved outcomes. “This is a fascinating new achievement in the search for novel treatments to significantly reduce the tissue damage and impaired organ function that occur following ischaemia in widespread and serious conditions such as heart attacks and strokes,” said Professor Schwaeble.

Share this post

PinIt
    scroll to top